These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2191038)

  • 21. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of interleukin-4 receptors on psoriatic epidermal cells.
    Prens E; Hegmans J; Lien RC; Debets R; Troost R; van Joost T; Benner R
    Am J Pathol; 1996 May; 148(5):1493-502. PubMed ID: 8623919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
    van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
    J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation and role of interleukin 6 in wounded human epithelial keratinocytes.
    Sugawara T; Gallucci RM; Simeonova PP; Luster MI
    Cytokine; 2001 Sep; 15(6):328-36. PubMed ID: 11594800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different properties of three isoforms (alpha, beta, and gamma) of transcription factor AP-2 in the expression of human keratinocyte genes.
    Oyama N; Takahashi H; Tojo M; Iwatsuki K; Iizuka H; Nakamura K; Homma Y; Kaneko F
    Arch Dermatol Res; 2002 Aug; 294(6):273-80. PubMed ID: 12192491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-1 and interleukin-6 in psoriasis.
    Prens EP; Benne K; van Damme J; Bakkus M; Brakel K; Benner R; van Joost T
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):121S-124S. PubMed ID: 2258628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased mRNA expression of manganese superoxide dismutase in psoriasis skin lesions and in cultured human keratinocytes exposed to IL-1 beta and TNF-alpha.
    Löntz W; Sirsjö A; Liu W; Lindberg M; Rollman O; Törmä H
    Free Radic Biol Med; 1995 Feb; 18(2):349-55. PubMed ID: 7744320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GRO-alpha mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo, but not in cultured keratinocytes.
    Kojima T; Cromie MA; Fisher GJ; Voorhees JJ; Elder JT
    J Invest Dermatol; 1993 Dec; 101(6):767-72. PubMed ID: 8245503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes.
    Mizutani H; Black R; Kupper TS
    J Clin Invest; 1991 Mar; 87(3):1066-71. PubMed ID: 1999487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of correlation between interleukin 6 and interleukin 1 levels in psoriatic lesional skin.
    Takematsu H; Tagami H
    Tohoku J Exp Med; 1994 Mar; 172(3):243-52. PubMed ID: 8073436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions.
    Ohta Y; Katayama I; Funato T; Yokozeki H; Nishiyama S; Hirano T; Kishimoto T; Nishioka K
    Arch Dermatol Res; 1991; 283(6):351-6. PubMed ID: 1796815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of inflammatory cytokines in psoriatic skin.
    Yoshinaga Y; Higaki M; Terajima S; Ohkubo E; Nogita T; Miyasaka N; Kawashima M
    Arch Dermatol Res; 1995; 287(2):158-64. PubMed ID: 7763087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporin A rapidly inhibits epidermal cytokine expression in psoriasis lesions, but not in cytokine-stimulated cultured keratinocytes.
    Elder JT; Hammerberg C; Cooper KD; Kojima T; Nair RP; Ellis CN; Voorhees JJ
    J Invest Dermatol; 1993 Dec; 101(6):761-6. PubMed ID: 8245502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An innovative three-dimensional model of normal human skin to study the proinflammatory psoriatic effects of tumor necrosis factor-alpha and interleukin-17.
    Donetti E; Cornaghi L; Gualerzi A; Baruffaldi Preis FW; Prignano F
    Cytokine; 2014 Jul; 68(1):1-8. PubMed ID: 24787050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The development and characterization of an in vitro model of psoriasis.
    Barker CL; McHale MT; Gillies AK; Waller J; Pearce DM; Osborne J; Hutchinson PE; Smith GM; Pringle JH
    J Invest Dermatol; 2004 Nov; 123(5):892-901. PubMed ID: 15482477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased levels of IL-1 alpha and beta in psoriatic lesional skin.
    Takematsu H; Ohmoto Y; Tagami H
    Tohoku J Exp Med; 1990 Jul; 161(3):159-69. PubMed ID: 2247888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-13 receptor in psoriatic keratinocytes: overexpression of the mRNA and underexpression of the protein.
    Cancino-Díaz JC; Reyes-Maldonado E; Bañuelos-Pánuco CA; Jiménez-Zamudio L; García-Latorre E; León-Dorantes G; Blancas-González F; Paredes-Cabrera G; Cancino-Díaz ME
    J Invest Dermatol; 2002 Nov; 119(5):1114-20. PubMed ID: 12445201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia.
    Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1995 Jul; 105(1 Suppl):89S-94S. PubMed ID: 7616005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.
    Grossman RM; Krueger J; Yourish D; Granelli-Piperno A; Murphy DP; May LT; Kupper TS; Sehgal PB; Gottlieb AB
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6367-71. PubMed ID: 2474833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
    Hammerberg C; Arend WP; Fisher GJ; Chan LS; Berger AE; Haskill JS; Voorhees JJ; Cooper KD
    J Clin Invest; 1992 Aug; 90(2):571-83. PubMed ID: 1386612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.